| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families.
|
Nat Genet
|
1994
|
4.15
|
|
2
|
Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer.
|
Nature
|
1998
|
2.98
|
|
3
|
Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family.
|
Proc Natl Acad Sci U S A
|
2000
|
2.06
|
|
4
|
Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families.
|
Am J Hum Genet
|
1995
|
1.85
|
|
5
|
FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4.
|
Cytokine
|
1999
|
1.83
|
|
6
|
The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis.
|
J Invest Dermatol
|
1984
|
1.35
|
|
7
|
BFIT, a unique acyl-CoA thioesterase induced in thermogenic brown adipose tissue: cloning, organization of the human gene and assessment of a potential link to obesity.
|
Biochem J
|
2001
|
1.17
|
|
8
|
The search for BRCA1.
|
Cancer Res
|
1994
|
1.11
|
|
9
|
22 genes from chromosome 17q21: cloning, sequencing, and characterization of mutations in breast cancer families and tumors.
|
Genomics
|
1995
|
1.09
|
|
10
|
Increased innervation of the vulval vestibule in patients with vulvodynia.
|
Br J Dermatol
|
2003
|
1.09
|
|
11
|
Growth inhibition of hepatoma cells induced by vitamin K and its analogs.
|
J Biol Chem
|
1995
|
1.03
|
|
12
|
Zidovudine plus interferon-alpha versus zidovudine alone in HIV-infected symptomatic or asymptomatic persons with CD4+ cell counts > 150 x 10(6)/L: results of the Zidon trial. Zidon Study Group.
|
AIDS
|
1995
|
0.93
|
|
13
|
The use of interferon-alpha in virus infections.
|
Drugs
|
1991
|
0.93
|
|
14
|
Suppression of p24 antigen in sera from HIV-infected individuals with low-dose alpha-interferon and zidovudine: a pilot study.
|
AIDS
|
1989
|
0.87
|
|
15
|
Letter: The mechanisms of action of vitamin B12.
|
J Am Chem Soc
|
1975
|
0.86
|
|
16
|
Treatment of melanoma by passive humoral immunotherapy using antibody drug synergism.
|
Lancet
|
1977
|
0.82
|
|
17
|
Partial growth-hormone insensitivity: the role of growth-hormone receptor mutations in idiopathic short stature.
|
J Pediatr
|
1997
|
0.82
|
|
18
|
Interaction of soluble pig heart glutamate-aspartate transaminase with various beta,gamma-unsaturated amino acids.
|
Biochem Biophys Res Commun
|
1985
|
0.79
|
|
19
|
Transition structures of the ene reactions of cyclopropene.
|
J Am Chem Soc
|
1997
|
0.77
|
|
20
|
A double-masked, placebo-controlled trial of acyclovir cream in immunocompetent patients with herpes zoster.
|
J Infect
|
1988
|
0.77
|
|
21
|
On the mechanism of action of vitamin B 12 . Model studies. Thermal rearrangement of methyl 3,3-dimethylglycidate to methyl levulinate.
|
Proc Natl Acad Sci U S A
|
1972
|
0.75
|
|
22
|
The role of chemo-attractant lipoxygenase products in the pathogenesis of psoriasis.
|
Br J Dermatol
|
1985
|
0.75
|
|
23
|
Vitamin B12S-promoted model rearrangement of methylmalonate to succinate is not a free radical reaction.
|
Proc Natl Acad Sci U S A
|
1990
|
0.75
|
|
24
|
Male intersexuality presenting at puberty.
|
Br J Obstet Gynaecol
|
1977
|
0.75
|
|
25
|
Efficient method for evaluation of the diffraction efficiency upper bound of diffractive phase elements.
|
Opt Lett
|
2000
|
0.75
|
|
26
|
Atypical multiple mole melanoma syndrome.
|
Br J Dermatol
|
1979
|
0.75
|
|
27
|
Letter: A nonenzymic model intermediate for the coenzyme B 12 dependent isomerization of methymalonyl coenzyme A to succinyl coenzyme A.
|
J Am Chem Soc
|
1976
|
0.75
|
|
28
|
Green pigs, red herrings, and a golden hoe: a retrospective on the identification of BRCA1 and the beginning of its characterization.
|
Cold Spring Harb Symp Quant Biol
|
1994
|
0.75
|
|
29
|
Inhibition of glutamate-aspartate transaminase by beta-methylene-DL-aspartate.
|
Biochem Pharmacol
|
1983
|
0.75
|
|
30
|
Multiple eccrine spiradenomata.
|
Br J Dermatol
|
1979
|
0.75
|
|
31
|
Beware a camouflage.
|
Aust Fam Physician
|
1993
|
0.75
|
|
32
|
Vitamin B-12 model studies. Migration of the acrylate fragment in the carbon-skeleton rearrangement leading to alpha-methyleneglutaric acid.
|
J Am Chem Soc
|
1976
|
0.75
|